Persistent URL of this record https://hdl.handle.net/1887/3505368
Documents
-
- Download
- 1-s2.0-S095980492101162X-main
- Publisher's Version
-
open access
- Full text at publishers site
In Collections
This item can be found in the following collections:
Life-prolonging treatment restrictions and outcomes in patients with cancer and COVID-19: an update from the Dutch Oncology COVID-19 Consortium
- All authors
- Joode, K. de; Tol, J.; Hamberg, P.; Cloos, M.; Kastelijn, E.A.; Borgers, J.S.W.; Nuij, V.J.A.A.; Klaver, Y.; Herder, G.J.M.; Mutsaers, P.G.N.J.; Dumoulin, D.W.; Oomen-de Hoop, E.; Diemen, N.G.J. van; Libourel, E.J.; Geraedts, E.J.; Bootsma, G.P.; Leest, C.H. van der; Peerdeman, A.L.; Herbschleb, K.H.; Visser, O.J.; Bloemendal, H.J.; Laarhoven, H.W.M. van; Vries, E.G.E. de; Hendriks, L.E.L.; Beerepoot, L.V.; Westgeest, H.M.; Berkmortel, F.W.P.J. van den; Haanen, J.B.A.G.; Dingemans, A.M.C.; Veldt, A.A.M. van der; DOCC Investigators
- Date
- 2022-01-01
- Journal
- European Journal of Cancer
- Volume
- 160
- Pages
- 261 - 272